Long-term efficacy of a new, fixed, very-low-dose angiotensin-converting enzyme-inhibitor/diuretic combination as first-line therapy in elderly hypertensive patients
- John Chalmers
- , Alain Castaigne
- , Trefor Morgan
- , Claude Chastang
Research output: Contribution to journal › Article › peer-review
74
Citations
(Scopus)